BioRestorative Therapies (BRTX) Current Assets (2010 - 2025)

BioRestorative Therapies (BRTX) has reported Current Assets for 16 consecutive years, with $3.1 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Current Assets fell 71.85% year-over-year to $3.1 million; the trailing twelve-month figure through Dec 2025 stood at $3.1 million (down 71.85% YoY), and the FY2025 full-year result was $3.1 million, down 71.85% from the prior year.
• Current Assets eased to $3.1 million in Q4 2025 per BRTX's latest filing, from $4.7 million in the prior quarter.
• Across five years, Current Assets topped out at $21.5 million in Q4 2021 and bottomed at $1.2 million in Q3 2021.
• Historically, Current Assets has averaged $11.4 million across 5 years, with a median of $12.3 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Current Assets soared 4794.93% in 2021, then sank 71.85% in 2025.
• Over 5 years, Current Assets stood at $21.5 million in 2021, then declined by 29.53% to $15.1 million in 2022, then dropped by 24.71% to $11.4 million in 2023, then decreased by 2.16% to $11.1 million in 2024, then tumbled by 71.85% to $3.1 million in 2025.
• According to Business Quant data, Current Assets over the past three periods registered $3.1 million, $4.7 million, and $7.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.